These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38151021)

  • 1. An electroencephalographic signature predicts craving for methamphetamine.
    Tian W; Zhao D; Ding J; Zhan S; Zhang Y; Etkin A; Wu W; Yuan TF
    Cell Rep Med; 2024 Jan; 5(1):101347. PubMed ID: 38151021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust identification of a neuromarker of methamphetamine craving.
    Parvaz MA; Bel-Bahar T
    Cell Rep Med; 2024 Feb; 5(2):101427. PubMed ID: 38382462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological correlate of incubation of craving in individuals with methamphetamine use disorder.
    Zhao D; Zhang M; Tian W; Cao X; Yin L; Liu Y; Xu TL; Luo W; Yuan TF
    Mol Psychiatry; 2021 Nov; 26(11):6198-6208. PubMed ID: 34385601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of rTMS treatment effects for methamphetamine use disorder based on EEG microstates.
    Li Y; Yang B; Ma J; Gao S; Zeng H; Wang W
    Behav Brain Res; 2024 May; 465():114959. PubMed ID: 38494128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted brain network dynamics and cognitive functions in methamphetamine use disorder: insights from EEG microstates.
    Chen T; Su H; Zhong N; Tan H; Li X; Meng Y; Duan C; Zhang C; Bao J; Xu D; Song W; Zou J; Liu T; Zhan Q; Jiang H; Zhao M
    BMC Psychiatry; 2020 Jun; 20(1):334. PubMed ID: 32580716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Intelligent Virtual-Reality System With Multi-Model Sensing for Cue-Elicited Craving in Patients With Methamphetamine Use Disorder.
    Tsai MC; Chung CR; Chen CC; Chen JY; Yeh SC; Lin CH; Chen YJ; Tsai MC; Wang YL; Lin CJ; Wu EH
    IEEE Trans Biomed Eng; 2021 Jul; 68(7):2270-2280. PubMed ID: 33571085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal Abnormalities Induced by an Intelligent Virtual Reality System for Methamphetamine Use Disorder.
    Chen CC; Tsai MC; Wu EH; Chung CR; Lee Y; Chiu PR; Tsai PY; Sheng SR; Yeh SC
    IEEE J Biomed Health Inform; 2022 Jul; 26(7):3458-3465. PubMed ID: 35226611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroplastic changes in resting-state functional connectivity after rTMS intervention for methamphetamine craving.
    Su H; Liu Y; Yin D; Chen T; Li X; Zhong N; Jiang H; Wang J; Du J; Xiao K; Xu D; Zeljic K; Wang Z; Zhao M
    Neuropharmacology; 2020 Sep; 175():108177. PubMed ID: 32505485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cue-induced craving and negative emotion disrupt response inhibition in methamphetamine use disorder: Behavioral and fMRI results from a mixed Go/No-Go task.
    Dakhili A; Sangchooli A; Jafakesh S; Zare-Bidoky M; Soleimani G; Batouli SAH; Kazemi K; Faghiri A; Oghabian MA; Ekhtiari H
    Drug Alcohol Depend; 2022 Apr; 233():109353. PubMed ID: 35249000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta coherence in resting-state EEG predicts the reduction in cigarette craving after hypnotic aversion suggestions.
    Li X; Ma R; Pang L; Lv W; Xie Y; Chen Y; Zhang P; Chen J; Wu Q; Cui G; Zhang P; Zhou Y; Zhang X
    Sci Rep; 2017 May; 7(1):2430. PubMed ID: 28546584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for the methamphetamine approach-avoidance training (MAAT) trial, a randomised controlled trial of personalised approach bias modification for methamphetamine use disorder.
    Garfield JBB; Piercy H; Arunogiri S; Lubman DI; Campbell SC; Sanfilippo PG; Gavin J; Hopwood M; Kotler E; George S; Okedara G; Piccoli LR; Manning V
    Trials; 2021 Jan; 22(1):21. PubMed ID: 33407781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Adenosine A2A receptor gene polymorphisms as risk factors of methamphetamine use disorder susceptibility and predictors of craving degree.
    Wang H; Ma Y; Wang X; Zhang W; Han W; Liu H; Li M; Xiao J; Wei H; Wang C; Sindhwani S; Zhang T; Guan F; Rice JP
    Psychiatry Res; 2022 Oct; 316():114790. PubMed ID: 35987070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of Magnetoencephalography and High-Density Electroencephalography Resting-State Functional Connectivity Metrics.
    Marquetand J; Vannoni S; Carboni M; Li Hegner Y; Stier C; Braun C; Focke NK
    Brain Connect; 2019 Sep; 9(7):539-553. PubMed ID: 31115272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased EEG gamma power under exposure to drug-related cues: a translational index for cue-elicited craving in METH-dependent individuals.
    Li DX; Zhou XY; Lin QQ; Wu Y; Hu C; Shen ZH; Wang YG
    BMC Psychiatry; 2023 May; 23(1):367. PubMed ID: 37231397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Series: Cariprazine for treatment of methamphetamine use disorder.
    Truong TT; Li B
    Am J Addict; 2022 Jan; 31(1):85-88. PubMed ID: 34713943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
    Kohno M; Dennis LE; McCready H; Schwartz DL; Hoffman WF; Korthuis PT
    Drug Alcohol Depend; 2018 Nov; 192():186-192. PubMed ID: 30266003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder.
    Jang WJ; Song SH; Son T; Bae JW; Lee S; Jeong CH
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12-h abstinence-induced functional connectivity density changes and craving in young smokers: a resting-state study.
    Zhao S; Li Y; Li M; Wang R; Bi Y; Zhang Y; Lu X; Yu D; Yang L; Yuan K
    Brain Imaging Behav; 2019 Aug; 13(4):953-962. PubMed ID: 29926324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Brain-Heart Relation in Patients With Methamphetamine Use Disorder During VR Induction of Drug Cue Reactivity.
    Chen CC; Chung CR; Tsai MC; Wu EH; Chiu PR; Tsai PY; Yeh SC
    IEEE J Transl Eng Health Med; 2024; 12():1-9. PubMed ID: 38059128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electroencephalographic signature predicts antidepressant response in major depression.
    Wu W; Zhang Y; Jiang J; Lucas MV; Fonzo GA; Rolle CE; Cooper C; Chin-Fatt C; Krepel N; Cornelssen CA; Wright R; Toll RT; Trivedi HM; Monuszko K; Caudle TL; Sarhadi K; Jha MK; Trombello JM; Deckersbach T; Adams P; McGrath PJ; Weissman MM; Fava M; Pizzagalli DA; Arns M; Trivedi MH; Etkin A
    Nat Biotechnol; 2020 Apr; 38(4):439-447. PubMed ID: 32042166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.